ENSHO THERAPEUTICS
Live / Applied — First extension granted (statement of use) (as of 08 Dec 2025)
What this means for you
Not registered yet, but its 31 Jul 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98675742
- Mark type
- Design + words
- Filed
- 31 Jul 2024
- Published for opposition
- 22 Apr 2025
- Attorney of record
- Nicole K. McLaughlin
Goods and services
- Class 005 — Pharmaceuticals: pharmaceuticals for the treatment and prevention of inflammatory bowel diseases and gastrointestinal diseases and disorders, including, ulcerative colitis and Crohn's disease
Owner
- Ensho Therapeutics, Inc., Morris Plains, NJ, US
- Ensho Therapeutics, Inc., Morris Plains, NJ, US
Prosecution history
- 09 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 Dec 2025 — SOU EXTENSION 1 GRANTED
- 08 Dec 2025 — SOU EXTENSION 1 FILED
- 08 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 17 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Apr 2025 — PUBLISHED FOR OPPOSITION
- 16 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 26 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Mar 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 24 Mar 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 24 Mar 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 20 Feb 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 20 Feb 2025 — NON-FINAL ACTION E-MAILED
- 20 Feb 2025 — NON-FINAL ACTION WRITTEN